BIIB News and Press, Biogen Inc. From 04/24/24

2024-04-24 11:25:25 ET Biogen Inc. (BIIB) Q1 2024 Earnings Call Transcript April 24, 2024 05:00 PM ET Company Participants Chuck Triano - Head of Investor Relations Chris Viehbacher - President and Chief Executive Officer Alisha Alaimo - Head and President of Nor...

2024-04-24 08:03:47 ET More on Biogen Biogen Inc. (BIIB) Stifel 2024 Virtual CNS Days (Transcript) Biogen Inc. (BIIB) TD Cowen 44th Annual Health Care Conference - (Transcript) Biogen's Q4 Earnings Disappoint Amidst Strategic Challenges (Rating Downgrade) Bio...

2024-04-24 07:45:39 ET Biogen Inc. (NASDAQ: BIIB), a leading biotechnology company, has released its Q1 2024 financial results , showcasing resilience and strategic growth despite facing revenue challenges. In the first quarter of 2024, Biogen reported a revenue of $2.29 billion...

Pegasystems Inc. (PEGA) is expected to report $0.2 for Q1 2024 Masco Corporation (MAS) is expected to report $0.87 for Q1 2024 Avery Dennison Corporation (AVY) is expected to report $2.15 for Q1 2024 Vista Energy S.A.B. de C.V. American Depositary Shares each representing one series A...

2024-04-24 06:51:46 ET More on Biogen Biogen Inc. (BIIB) Stifel 2024 Virtual CNS Days (Transcript) Biogen Inc. (BIIB) TD Cowen 44th Annual Health Care Conference - (Transcript) Biogen's Q4 Earnings Disappoint Amidst Strategic Challenges (Rating Downgrade) Bio...

2024-04-23 11:01:17 ET More on Biogen Biogen Inc. (BIIB) Stifel 2024 Virtual CNS Days (Transcript) Biogen Inc. (BIIB) TD Cowen 44th Annual Health Care Conference - (Transcript) Biogen's Q4 Earnings Disappoint Amidst Strategic Challenges (Rating Downgrade) Bio...

2024-04-22 16:25:01 ET More on S&P 500 Index: Why AI Stocks Could Go Boom Fed's Commercial Banking Report Shows Economic Headwinds, But Deposit Growth Bucks Trend S&P 500: Capitulation? Week Starting 22nd April (Technical Analysis) Nasdaq, S&P, an...

2024-04-22 00:58:35 ET Summary The FDA has convened an advisory panel to discuss the safety and efficacy of Eli Lilly's anti-amyloid antibody drug donanemab. Approval of donanemab could have a modestly positive impact on LLY stock, while denial could lead to a substantial (but not...

2024-04-21 08:00:00 ET As the market gears up for another eventful earnings week, investors are eagerly anticipating reports from a wide array of companies across various sectors. Big names like Tesla ( NASDAQ: TSLA ), Microsoft ( NASDAQ: MSFT ), Alphabet ( NASDAQ: GOOG ...

2024-04-19 11:56:37 ET The selloff in the S&P 500 over the past couple of weeks has pulled certain stocks into what is considered oversold territory, according to the relative strength index technical indicator.... Read the full article on Seeking Alpha For further details s...